Skip to content
Screener

CapEx at other companies

IAR
Integra LifeSciencesIART
$12.31M-38.9%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$334K-71.2%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$1.1M-69.8%
Solventum logo
SolventumSOLV
$83M-24.5%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$1.28M+247%
CorMedix logo
CorMedixCRMD
$729K+7,190%

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$632.6M-39.3%
Enterprise value$513.97M-45.4%
P/E101.4×+69.0×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireMachineryAndEquipment.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Net cash flows (used in) provided by operating activities(8,136)19,718
Cash flows from investing activities:
Cash paid for acquisitions(5,000)(700)
Purchases of equipment(1,168)(556)
Patent application costs(109)(37)
Net cash flows used in investing activities(6,277)(1,293)
Cash flows from financing activities:
Cash paid for share repurchases pursuant to Share Repurchase Plan(12,468)

Item 1. Financial Statements

FAQ

What is MiMedx Group's capex?
MiMedx Group (MDXG) reported capex of $598K in Q2 2026.
How has MiMedx Group's capex changed year-over-year?
MiMedx Group's capex increased by 234.1% year-over-year, from $179K to $598K.
What is the long-term trend for MiMedx Group's capex?
Over 4 years (2021 to 2025), MiMedx Group's capex has grown at a -24.7% compound annual growth rate (CAGR), from $3.22M to $1.03M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about MiMedx Group's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude